General Information
Drug ID
DR00102
Drug Name
Dinoprostone
Synonyms
(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
Drug Type
Small molecular drug
Indication Medical abortion [ICD11: JA00.1] Approved [1]
Therapeutic Class
Prostaglandins
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5280360"></iframe>
3D MOL 2D MOL
Formula
C20H32O5
Canonical SMILES
CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O
InChI
InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1
InChIKey
XEYBRNLFEZDVAW-ARSRFYASSA-N
CAS Number
CAS 363-24-6
Pharmaceutical Properties Molecular Weight 352.471 Topological Polar Surface Area 94.8
Heavy Atom Count 25 Rotatable Bond Count 12
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 5
XLogP
2.8
PubChem CID
5280360
PubChem SID
103176817 , 10321741 , 104017641 , 104046436 , 14778621 , 14900948 , 24898100 , 24898683 , 24898775 , 26753268 , 26753269 , 26753270 , 26759401 , 3139923 , 3727087 , 3863 , 39289526 , 4265954 , 439749 , 450259 , 46505549 , 47662021 , 47810515 , 47885164 , 48415907 , 50026789 , 50087222 , 50105678 , 50105679 , 53789659 , 56313306 , 56314112 , 56459056 , 57357707 , 599053 , 75054349 , 7847147 , 7979101 , 803734 , 8143217 , 85789494 , 85856640 , 8616235 , 92298396 , 92308753 , 92309906 , 92722489 , 99300820 , 99302338 , 99431525
ChEBI ID
ChEBI:15551
TTD Drug ID
D06FEA
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [3]
OAT1 Transporter Info Organic anion transporter 1 Substrate [4]
OAT2 Transporter Info Organic anion transporter 2 Substrate [4]
OAT3 Transporter Info Organic anion transporter 3 Substrate [4]
OAT4 Transporter Info Organic anion transporter 4 Substrate [4]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [5]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [6]
OATP1C1 Transporter Info Organic anion transporting polypeptide 1C1 Substrate [7]
OATP2A1 Transporter Info Organic anion transporting polypeptide 2A1 Substrate [8]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [8]
OATP3A1 Transporter Info Organic anion transporting polypeptide 3A1 Substrate [9]
OATP4A1 Transporter Info Organic anion transporting polypeptide 4A1 Substrate [8]
OATP5A1 Transporter Info Organic anion transporting polypeptide 5A1 Substrate [10]
OCT1 Transporter Info Organic cation transporter 1 Substrate [11]
OCT2 Transporter Info Organic cation transporter 2 Substrate [11]
OSTalpha Transporter Info Organic solute transporter subunit alpha Substrate [12]
OSTalpha Transporter Info Organic solute transporter subunit alpha Substrate [12]
OSTbeta Transporter Info Organic solute transporter subunit beta Substrate [12]
OSTbeta Transporter Info Organic solute transporter subunit beta Substrate [12]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MRP4 Transporter Info Km = 3.4 microM Spodoptera frugiperda (Sf9) cells-MRP4 [3]
OAT1 Transporter Info Km = 0.97 microM Proximal tubule (S2) cells-OAT1 [4]
OAT2 Transporter Info Km = 0.713 microM Proximal tubule (S2) cells-OAT2 [4]
OAT3 Transporter Info Km = 0.345 microM Proximal tubule (S2) cells-OAT3 [4]
OAT4 Transporter Info Km = 0.154 microM Proximal tubule (S2) cells-OAT4 [4]
OCT1 Transporter Info Km = 0.657 microM Proximal tubule (S2) cells-OCT1 [4]
OCT2 Transporter Info Km = 0.0289 microM Proximal tubule (S2) cells-OCT2 [4]
References
1 Dinoprostone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 2006 Apr;26(3):362-8.
3 The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9244-9.
4 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
5 Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 2001 Nov;443(2):188-95.
6 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.
7 Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol. 2002 Oct;16(10):2283-96.
8 Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60.
9 Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol. 2003 Dec;285(6):F1188-97.
10 Expression and regulation of prostaglandin transporters, ATP-binding cassette, subfamily C, member 1 and 9, and solute carrier organic anion transporter family, member 2A1 and 5A1 in the uterine endometrium during the estrous cycle and pregnancy in pigs. Asian-Australas J Anim Sci. 2017 May;30(5):643-652.
11 Are organic cation transporters capable of transporting prostaglandins? Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):125-30.
12 Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem. 2003 Jul 25;278(30):27473-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.